Company Logo

obinutuzumab

Agricultural Biotechnology

Updated on Jul 4, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for obinutuzumab with ID of: 4305433
Recombinant Humanized (from mouse) antibody to Human MS4A1. Obinutuzumab was approved under the tradename obinutuzumab by the US FDA in 2013, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.